The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With Dementia
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to evaluate the safety and efficacy of high-dose donepezil (23mg)
in Parkinson's disease with dementia compared to standard dose donepezil.